Dynamic Technology Lab Private Ltd Purchases Shares of 3,450 CME Group Inc. $CME

Key Points

• Dynamic Technology Lab Private Ltd has made a new investment of approximately $915,000 in CME Group Inc., acquiring 3,450 shares.
• Multiple large investors, including Bank Pictet & Cie Europe AG, have recently increased their stakes in CME Group, leading to institutional ownership of 87.75% of the company's stock.
• CME Group declared a quarterly dividend of $1.25 per share, with an annualized dividend yield of 1.9%, reflecting a payout ratio of 48.40%.

Dynamic Technology Lab Private Ltd bought a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,450 shares of the financial services provider's stock, valued at approximately $915,000.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in CME Group by 1.2% in the first quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock valued at $9,190,661,000 after buying an additional 400,737 shares during the period. Raymond James Financial Inc. lifted its stake in CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock valued at $1,091,401,000 after buying an additional 363,130 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in CME Group by 29.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock valued at $747,744,000 after buying an additional 648,591 shares during the period. AQR Capital Management LLC lifted its stake in CME Group by 10.3% in the first quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider's stock valued at $735,539,000 after buying an additional 260,065 shares during the period. Finally, Wellington Management Group LLP lifted its stake in CME Group by 370.5% in the first quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after buying an additional 2,089,935 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Down 0.0%

Shares of NASDAQ:CME traded down $0.08 during mid-day trading on Friday, reaching $262.30. 1,485,860 shares of the stock were exchanged, compared to its average volume of 2,297,557. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $94.53 billion, a P/E ratio of 25.39, a P/E/G ratio of 4.70 and a beta of 0.43. CME Group Inc. has a one year low of $212.38 and a one year high of $290.79. The stock's 50 day simple moving average is $273.85 and its 200-day simple moving average is $270.21.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group's quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the company earned $2.56 earnings per share. As a group, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on CME shares. Oppenheimer increased their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a research note on Thursday, July 24th. Citigroup raised their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. UBS Group dropped their price target on CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday. Piper Sandler raised their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Finally, Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $260.60.

Insider Transactions at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director William R. Shepard purchased 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was bought at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the purchase, the director owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is currently owned by company insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.